Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 022336/0019 | |
| Pages: | 6 |
| | Recorded: | 03/03/2009 | | |
| Attorney Dkt #: | 32678-US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10527553
|
Filing Dt:
|
09/09/2005
|
|
Publication #:
|
|
Pub Dt:
|
05/11/2006
| | | | |
|
Title:
|
Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
|
|
|
Assignee
|
|
|
|
|
| LICHTSTRASSE 35 |
| BASEL, SWITZERLAND 4056 |
|
|
Correspondence name and address
|
| |
LINDA ADAMS
|
| |
NOVARTIS PHARMACEUTICALS CORP.
|
| |
ONE HEALTH PLAZA
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
06/25/2024 08:33 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
